Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
Genes, Androgens and Intrauterine Environment in PCOS
1 other identifier
observational
70
1 country
1
Brief Summary
Polycystic ovary syndrome (PCOS) is among the most common endocrine disorders in premenopausal women, affecting 7-10% of this population. This syndrome is characterized by elevated levels of testosterone and chronic anovulation, and frequently of obesity. This study is designed to test the hypothesis that there is in utero testosterone excess, altered insulin secretion, and/or intrauterine growth retardation in the female offspring of women with PCOS. The allele 8 can be used to identify the reproductive and metabolic abnormalities associated with PCOS. This study will determine whether allele 8 positive \[A8(+)\] female offspring have more profound changes in these parameters compared to A8(-) female offspring. Androgen and insulin levels in amniotic fluid from pregnant women with PCOS will be compared to levels in pregnant control women. Androgen and insulin levels in cord blood will also be measured. Further, gestational age and anthropomorphic measurements in offspring of women with PCOS will be assessed and compared to that in offspring of matched control women. We will test the hypothesis that androgens are elevated in infancy in the female offspring of women with PCOS. We will assess sex steroids, insulin, and c-peptide levels in infants of PCOS women and compare them to the levels in infants of control women up to 1 year of age during the minipuberty of infancy. We will determine whether any of these parameters differ in A8(+) compared to A8(-) PCOS offspring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 15, 2006
CompletedFirst Posted
Study publicly available on registry
August 16, 2006
CompletedResults Posted
Study results publicly available
August 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedApril 10, 2013
April 1, 2013
9.5 years
August 15, 2006
July 19, 2010
April 3, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Estradiol Level in Female Offspring
The blood that were analyzed were taken from cord blood and not from the offspring.
One time sampling from the cord blood
Androstenedione Level in Female Offspring
cord blood
Testosterone Level in Female Offspring
cord blood
17-hydroxyprogesterone Level in Female Offspring
cord blood
Dihydrotestosterone Level in Female Offspring
cord blood
Dehydroepiandrosterone Level in Female Offspring
cord blood
Infant Birth Weight (Male and Female)
birth
Eligibility Criteria
Women with PCOS and control women and their offspring
You may not qualify if:
- history of gestational diabetes mellitus, eclampsia, pre-eclampsia or any medical disorders complicating their pregnancies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University School of Medicine
Chicago, Illinois, 60611, United States
Biospecimen
blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Andrea Dunaif
- Organization
- Northwestern University
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea E Dunaif, MD
Chief, Division of Endocrinology, Metabolism and Molecular Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Charles F Kettering Professor of Endocrinology & Metabolism Vice Chair for Research, Department of Medicine
Study Record Dates
First Submitted
August 15, 2006
First Posted
August 16, 2006
Study Start
January 1, 2003
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
April 10, 2013
Results First Posted
August 18, 2010
Record last verified: 2013-04